| 12264173 |
Antiviral compounds |
Gregory Chin, Byoung-Kwon Chun, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Hon Chung Hui +3 more |
2025-04-01 |
|
| 12110294 |
CD73 compounds |
Mark J. Bartlett, Gregory Chin, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan +9 more |
2024-10-08 |
$323,137,000 |
| 11919869 |
CD73 compounds |
Mark J. Bartlett, Gregory Chin, Michael O' Neil Hanrahan Clarke, Jennifer L. Cosman, Deeba Ensan +6 more |
2024-03-05 |
$494,028,000 |
| 11767337 |
Antiviral compounds |
Gregory Chin, Byoung-Kwon Chun, Michael O' Neil Hanrahan Clarke, Bindu Goyal, Hon Chung Hui +3 more |
2023-09-26 |
$541,194,000 |
| 11179397 |
Imidazopyrimidine derivatives |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Xiaochun Han, Tim Hansen, Yunfeng Eric Hu +6 more |
2021-11-23 |
$216,502,000 |
| 10174038 |
Compounds and methods for antiviral treatment |
Hon Chung Hui, Jay P. Parrish, Michael Sangi, Dustin Siegel, David Sperandio |
2019-01-08 |
$217,992,000 |
| 10017501 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2018-07-10 |
$525,460,000 |
| 9957275 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2018-05-01 |
$363,238,000 |
| 9951065 |
Benzimidazole and imadazopyridine carboximidamide compounds |
Mark J. Bartlett, Julian A. Codelli, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel +4 more |
2018-04-24 |
$155,957,000 |
| 9504689 |
Compounds and methods for antiviral treatment |
Dustin Siegel, David Sperandio, Michael Sangi, Jay P. Parrish, Hon Chung Hui |
2016-11-29 |
$181,866,000 |
| 9458145 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2016-10-04 |
$144,218,000 |
| 9453062 |
Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof |
Tao Ma, Shusen XU, Zhijun Liu, Bo Zhang, Ning Shen +4 more |
2016-09-27 |
|
| 9255089 |
Benzimidazolone derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +8 more |
2016-02-09 |
$342,012,000 |
| 9238039 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2016-01-19 |
$613,553,000 |
| 9108953 |
Quinoline derivatives as bromodomain inhibitors |
Kerim Babaoglu, Britton Kenneth Corkey, Robert Jiang, David Sperandio |
2015-08-18 |
$1,129,469,000 |
| 8999969 |
Anti-RSV compounds |
Richard L. Mackman, David Sperandio |
2015-04-07 |
$530,723,000 |
| 8980878 |
Compounds and methods for antiviral treatment |
Dustin Siegel, David Sperandio, Michael Sangi, Jay P. Parrish, Hon Chung Hui |
2015-03-17 |
$534,621,000 |
| 8946238 |
Pyrazolo[1,5-A]pyrimidines as antiviral agents |
Constantine G. Boojamra, Hon Chung Hui, Petr Jansa, Richard L. Mackman, Jay P. Parrish +3 more |
2015-02-03 |
$1,001,938,000 |
| 8809330 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2014-08-19 |
$228,809,000 |
| 8486938 |
Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2013-07-16 |
$295,019,000 |